These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11423171)

  • 1. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.
    Roelen DL; Stobbe I; Young NT; van Bree SP; Doxiadis II; Oudshoorn M; Morris PJ; Wood KJ; Claas FH
    Hum Immunol; 2001 Jul; 62(7):661-7. PubMed ID: 11423171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation.
    van der Meer A; Joosten I; Schattenberg AV; de Witte TJ; Allebes WA
    Br J Haematol; 2000 Nov; 111(2):685-94. PubMed ID: 11122122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.
    Dankers MK; Roelen DL; Van Der Meer-Prins EM; De Lange P; Korfage N; Smits JM; Persijn GG; Welsh KI; Doxiadis II; Claas FH
    Transplantation; 2003 Feb; 75(3):418-20. PubMed ID: 12589169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
    Oudshoorn M; Doxiadis II; van den Berg-Loonen PM; Voorter CE; Verduyn W; Claas FH
    Hum Immunol; 2002 Mar; 63(3):176-84. PubMed ID: 11872235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.
    Stobbe I; van der Meer-Prins E; Smits JM; Doxiadis II; Claas FH
    Transpl Immunol; 1999 Dec; 7(4):215-20. PubMed ID: 10638834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
    Speiser DE; Löliger CC; Siren MK; Jeannet M
    Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens.
    Roelen DL; van Bree SP; van Beelen E; Schanz U; van Rood JJ; Claas FH
    Transplantation; 1994 Feb; 57(3):446-50. PubMed ID: 8108881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching.
    Stobbe I; van der Meer-Prins EM; de Lange P; Oudshoorn M; Doxiadis II; Claas FH
    Hum Immunol; 2000 Sep; 61(9):879-83. PubMed ID: 11053631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors.
    Zhang L; van Bree S; van Rood JJ; Claas FH
    Transplantation; 1990 Dec; 50(6):1008-10. PubMed ID: 2256142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors.
    Jeras M
    Transpl Immunol; 2002 Aug; 10(2-3):205-14. PubMed ID: 12216951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens.
    Falkenburg JH; van Luxemburg-Heijs SA; Lim FT; Kanhai HH; Willemze R
    Ann Hematol; 1996 Apr; 72(4):260-4. PubMed ID: 8624381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
    Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of cytotoxic T-lymphocyte precursor frequencies against HLA class I antigens in responder-stimulator pairs with a negative mixed lymphocyte culture reaction.
    Slavcev AS; Breur-Vriesendorp BS; Ivanyi P
    Hum Immunol; 1995 Oct; 44(2):97-102. PubMed ID: 8847234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of permissible HLA mismatches.
    Takemoto S; Terasaki PI
    Clin Transpl; 1994; ():451-66. PubMed ID: 7547575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.
    Kaminski ER; Hows JM; Bridge J; Davey NJ; Brookes PA; Green JE; Goldman JM; Batchelor JR
    Bone Marrow Transplant; 1991 Jul; 8(1):47-50. PubMed ID: 1912955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.